Orchestra BioMed Holdings, Inc. - OBIO

About Gravity Analytica
Recent News
- 04.23.2025 - Blog Post – Yesterday’s FDA Breakthrough Device Designation News
- 04.23.2025 - Blog Post – Yesterday’s FDA Breakthrough Device Designation News
- 04.23.2025 - Orchestra BioMed Announces AVIM Therapy-Focused Satellite Symposium at HRS 2025 Annual Meeting
- 04.23.2025 - Orchestra BioMed Announces AVIM Therapy-Focused Satellite Symposium at HRS 2025 Annual Meeting
- 04.22.2025 - Blog Post - AVIM Therapy Breakthrough Device Designation Shareholder Implications
- 04.22.2025 - Blog Post - AVIM Therapy Breakthrough Device Designation Shareholder Implications
- 04.22.2025 - Orchestra BioMed Receives FDA Breakthrough Device Designation for AVIM Therapy
- 04.22.2025 - Orchestra BioMed Receives FDA Breakthrough Device Designation for AVIM Therapy
- 04.22.2025 - Orchestra BioMed Receives FDA Breakthrough Device Designation for AVIM Therapy
- 04.22.2025 - Orchestra BioMed Receives FDA Breakthrough Device Designation for AVIM Therapy
Recent Filings
- 04.04.2025 - 4 Statement of changes in beneficial ownership of securities
- 04.04.2025 - 4 Statement of changes in beneficial ownership of securities
- 04.04.2025 - 4 Statement of changes in beneficial ownership of securities
- 04.04.2025 - 4 Statement of changes in beneficial ownership of securities
- 03.31.2025 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]
- 03.28.2025 - 4 Statement of changes in beneficial ownership of securities